Wegovy tablet accepted by US FDA for weight reduction | EUROtoday

The US Food and Drug Administration has accepted a tablet model of the weight-loss drug Wegovy, in response to maker Novo Nordisk.

It marks a primary on this new period of weight-loss drugs with Wegovy being the one to this point to achieve approval for the tablet model of their GLP-1 drug, which has solely been obtainable as an injection.

Wegovy’s Danish makers Novo Nordisk stated the once-daily tablet was a “convenient option” to the inject-able and would supply the identical weight reduction because the shot. It comes after Wegovy was accepted by the FDA particularly for weight reduction.

Others like Ozempic, which has comparable weight-loss results, have been primarily accepted for the therapy of Type 2 diabetes.